30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Akshay Vaishnaw

Track

Insider profile

Currently holds positions in Editas Medicine Inc and Alnylam Pharmaceuticals Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 40% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Editas Medicine Inc July 28, 2016 -
President - Research and Development Alnylam Pharmaceuticals Inc March 1, 2018 -
Independent Director Scholar Rock Holding Corp May 21, 2019 - May 29, 2020
Executive Vice President - Research and Development Alnylam Pharmaceuticals Inc Jan. 3, 2017 - March 1, 2018
Executive Vice President - Research and Development ,Chief Medical Officer Alnylam Pharmaceuticals Inc Dec. 1, 2014 - Jan. 3, 2017
Executive Vice President, Chief Medical Officer Alnylam Pharmaceuticals Inc June 21, 2012 - Dec. 1, 2014
Senior Vice President, Chief Medical Officer Alnylam Pharmaceuticals Inc June 9, 2011 - June 21, 2012
Akshay Vaishnaw's trades of Scholar Rock Holding Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-20 2026-04-16
S Sale
70,289 -8.4%
408.62
US$2,367,932 		70,289 -8.4% 408.62 US$2,367,932
2026-01-15 2026-01-13
S Sale
65,458 +20.3%
225.22
US$4,663,509 		65,458 +20.3% 225.22 US$4,663,509
2025-05-30 2025-05-29
PlS Planned sale
56,437 +19.4%
34.68
US$4,295,142 		56,437 +19.4% 34.68 US$4,295,142
2025-05-30 2025-05-29
PlS Planned sale
5,130 -0.8%
29.63
US$152,000 		5,130 -0.8% 29.63 US$152,000
2025-05-29 2025-05-29
PrS Proposed sale
6,750
29.66
US$200,205 		6,750 29.66 US$200,205
2023-12-11 2023-12-11
PrS Proposed sale
10,832
170.04
US$1,841,873 		10,832 170.04 US$1,841,873
2023-08-07 2023-08-04
S Sale
192 -0.8%
189.31
US$36,348 		192 -0.8% 189.31 US$36,348
2023-08-07 2023-08-04
S Sale
17 -0.1%
188.40
US$3,203 		17 -0.1% 188.40 US$3,203
2023-08-07 2023-08-04
S Sale
101 -0.4%
187.37
US$18,924 		101 -0.4% 187.37 US$18,924
2023-08-07 2023-08-04
S Sale
1,107 -4.6%
186.39
US$206,334 		1,107 -4.6% 186.39 US$206,334
2023-08-07 2023-08-04
S Sale
1,869 -7.2%
185.54
US$346,774 		1,869 -7.2% 185.54 US$346,774
2023-08-07 2023-08-04
S Sale
771 -2.9%
184.70
US$142,404 		771 -2.9% 184.70 US$142,404
2023-04-28 2023-04-27
S Sale
168 -0.9%
197.08
US$33,109 		168 -0.9% 197.08 US$33,109
2023-04-28 2023-04-27
S Sale
104 -0.6%
195.65
US$20,348 		104 -0.6% 195.65 US$20,348
2023-04-28 2023-04-27
S Sale
1,013 -5.3%
194.94
US$197,474 		1,013 -5.3% 194.94 US$197,474
2023-04-28 2023-04-27
S Sale
910 -4.5%
193.93
US$176,476 		910 -4.5% 193.93 US$176,476
2023-04-28 2023-04-27
S Sale
197 -1.0%
193.18
US$38,056 		197 -1.0% 193.18 US$38,056
2023-02-14 2023-02-10
PlS Planned sale
4,302 -22.3%
217.05
US$933,749 		4,302 -22.3% 217.05 US$933,749
2023-02-14 2023-02-10
PlS Planned sale
19,447 -50.2%
216.38
US$4,207,942 		19,447 -50.2% 216.38 US$4,207,942
2023-02-14 2023-02-10
PlS Planned sale
10,279 -21.0%
215.59
US$2,216,050 		10,279 -21.0% 215.59 US$2,216,050
2023-02-14 2023-02-10
PlS Planned sale
2,307 -4.5%
214.28
US$494,344 		2,307 -4.5% 214.28 US$494,344
2023-02-14 2023-02-10
PlS Planned sale
1,709 -3.2%
213.13
US$364,239 		1,709 -3.2% 213.13 US$364,239
2021-12-23 2021-12-23
PlS Planned sale
303 -2.6%
195.11
US$59,118 		303 -2.6% 195.11 US$59,118
2021-12-23 2021-12-23
PlS Planned sale
145 -1.2%
193.67
US$28,082 		145 -1.2% 193.67 US$28,082
2021-12-23 2021-12-23
PlS Planned sale
126 -1.1%
193.37
US$24,365 		126 -1.1% 193.37 US$24,365
2021-12-23 2021-12-23
PlS Planned sale
73 -0.6%
192.25
US$14,034 		73 -0.6% 192.25 US$14,034
2021-12-23 2021-12-23
PlS Planned sale
1,000 -7.8%
191.45
US$191,450 		1,000 -7.8% 191.45 US$191,450
2021-12-23 2021-12-23
PlS Planned sale
125 -1.0%
190.86
US$23,858 		125 -1.0% 190.86 US$23,858
2021-12-23 2021-12-23
PlS Planned sale
142 -1.1%
190.39
US$27,035 		142 -1.1% 190.39 US$27,035
2021-12-23 2021-12-23
PlS Planned sale
73 -0.6%
190.33
US$13,894 		73 -0.6% 190.33 US$13,894
2021-12-23 2021-12-23
PlS Planned sale
5 -0.0%
190.27
US$951 		5 -0.0% 190.27 US$951
2021-12-23 2021-12-23
PlS Planned sale
144 -1.1%
190.02
US$27,363 		144 -1.1% 190.02 US$27,363
2021-12-23 2021-12-23
PlS Planned sale
144 -1.1%
189.24
US$27,251 		144 -1.1% 189.24 US$27,251
2021-12-23 2021-12-23
PlS Planned sale
8 -0.1%
189.18
US$1,513 		8 -0.1% 189.18 US$1,513
2021-12-23 2021-12-23
PlS Planned sale
73 -0.5%
189.01
US$13,798 		73 -0.5% 189.01 US$13,798
2021-12-23 2021-12-23
PlS Planned sale
127 -0.9%
188.26
US$23,909 		127 -0.9% 188.26 US$23,909
2021-12-23 2021-12-23
PlS Planned sale
130 -0.9%
187.35
US$24,356 		130 -0.9% 187.35 US$24,356
2021-12-23 2021-12-23
PlS Planned sale
137 -1.0%
187.08
US$25,630 		137 -1.0% 187.08 US$25,630
2021-12-23 2021-12-23
PlS Planned sale
124 -0.9%
186.22
US$23,091 		124 -0.9% 186.22 US$23,091
2021-08-11 2021-08-09
PlS Planned sale
10,834 -49.1%
200.00
US$2,166,800 		10,834 -49.1% 200.00 US$2,166,800
2021-06-22 2021-06-18
PlS Planned sale
14,708 -56.7%
175.00
US$2,573,900 		14,708 -56.7% 175.00 US$2,573,900
2021-04-21 2021-04-21
PlS Planned sale
107 -0.8%
138.48
US$14,817 		107 -0.8% 138.48 US$14,817
2021-04-21 2021-04-21
PlS Planned sale
530 -3.6%
137.60
US$72,928 		530 -3.6% 137.60 US$72,928
2021-04-21 2021-04-21
PlS Planned sale
1,892 -11.4%
136.84
US$258,901 		1,892 -11.4% 136.84 US$258,901
2021-04-21 2021-04-21
PlS Planned sale
203 -1.2%
135.41
US$27,488 		203 -1.2% 135.41 US$27,488